Basepaws

Basepaws is a pet genetics company. The first company of its kind, Basepaws created a direct-to-consumer feline DNA test, focusing on delivering breed and trait information and actionable health insights. Each test reveals the genetic breakdown of the cat, with results that explain breed composition and health markers. As more owners add to the growing database, future reports will be able to link results with potential diseases and nutrition needs. We work closely with pet owners, veterinarians, breeders, shelters and pet nutrition companies, and will use genomic data in a variety of fields including pet nutrition and therapeutics. Our products are built on proprietary cost-saving sequencing technology which combines whole genome sequencing with the specificity of amplicon approaches. Our tests are available in various online and offline channels, and the database built will be used in creation of additional products and services, such as personalized pet food and pet health coaching.

Basepaws headquartered in United States, North America, operates in the Biotechnology, Consumer, Pet sector. The company focuses on Biotechnology and has secured $21.1M in funding across 84 round(s). With a team of 11-50 employees, Basepaws is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Basepaws, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.